Antibiotic—Lysobacter enzymogenes proteases combination as a novel virulence attenuating therapy
Sign Up to like & getrecommendations! Published in 2023 at "PLOS ONE"
DOI: 10.1371/journal.pone.0282705
Abstract: Minimizing antibiotic resistance is a key motivation strategy in designing and developing new and combination therapy. In this study, a combination of the antibiotics (cefixime, levofloxacin and gentamicin) with Lysobacter enzymogenes (L. enzymogenes) bioactive proteases… read more here.
Keywords: antibiotic lysobacter; enzymogenes cfs; lysobacter enzymogenes; combination ... See more keywords